ENDOCRINOLOGY AND METABOLISM

Goals: The division plans to expand diabetes research, both basic and clinical, by recruiting new faculty. It will also recruit new faculty and involve more existing faculty in other areas of research.

Clinical Areas of Excellence:
robust clinical service focused on patients with diabetes, thyroid disease, metabolic bone disease, pituitary and adrenal disorders; catchment area covers the entire state of Indiana and, for rare disorders, extends well beyond the state

Education Areas of Excellence:
leadership in the Endocrine, Reproductive, Musculoskeletal, and Dermatologic Systems course for second year medical students and very active endocrine rotations for students and residents; very high caliber of fellows; very active conference schedule with three weekly conferences (endocrine grand rounds, endocrine case conference, and metabolic bone case conference); research conference for all diabetes investigators through the Diabetes Center

Research Areas of Excellence:
diabetes, obesity, metabolic bone disease, and rare metabolic disease research; developing strength in pituitary disease. The division’s diabetes research spans from cell culture and animal model studies, to clinical research to community focused research. Its research in metabolic bone and mineral disorders involves cell culture, animal models, clinical research and informatic studies using the Indiana Network for Patient Care.

LEADERSHIP & ADMINISTRATION

MICHAEL ECONS, MD
Distinguished Professor of Medicine
Division Director

MELISSA CAVAGHAN, MD
Associate Professor of Clinical Medicine
Service Line Leader

LESLIE MILLER
Division Administrator

TONYA SOMERS
Service Line Administrator

FEATURED FACULTY

ZEB SAAED, MD
Assistant Professor of Clinical Medicine

• Associate Fellowship Director in 2023
• Serves as Associate Clerkship Director for Phase 2 (MS3) with focus on curriculum development
• Received the Outstanding Clinical Teaching Award in Internal Medicine by the class of 2022
• Grant submitted to National Board of Medical Examiners (NBME) Stemmler Fund on learner assessment

ERIK IMEL, MD
Professor Medicine

• Co-Chair of the 2022 Pre-Meeting Symposium for the American Society for Bone and Mineral Research (ASBMR)
• Recognized for his ongoing research in musculoskeletal health informatics, research in rare bone diseases, and in clinical research protocols

CARMELLA EVANS-MOLINA, MD, PHD
Professor of Medicine

• Lauded for her broad use of cell biology, animal models, and human studies to study the pathogenesis of Type 1 and Type 2 Diabetes, in addition to clinical validation of biomarkers and target identification in clinical trials of disease modifying therapies

FELLOWSHIPS

Endocrinology, Diabetes, and Metabolism Fellowship (two years)
Director: Amale A. Lteif, MD

NOTABLE PUBLICATIONS

Donegan D, Saeed Z, Delivanis DA, Murad MH, Honegger J, Amereller F, Oguz SH, Erickson D, Bancos I. Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2022 Mar 24;107(4):1170-1190. doi: 10.1210/clinem/ dgab839. PMID: 35137155; PMCID: PMC8947799.

Weber TJ, Imel EA, Carpenter TO, Peacock M, Portale AA, Hetzer J, Merritt JL, Insogna K. Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia. J Clin Endocrinol Metab. 2022 Dec 17;108(1):155-165. doi: 10.1210/clinem/dgac518. PMID: 36072994; PMCID: PMC9759172.

Econs MJ, Selen DJ, Balza R, Zurkiya O, Kronenberg HM, Hung YP. Case 18-2022: A 29-Year-Old Woman with Recurrent Fractures. N Engl J Med. 2022 Jun 16;386(24):2316-2326. doi: 10.1056/ NEJMcpc2107348. PMID: 35704485.

ASSOCIATED RESEARCH CENTERS

Center for Diabetes and Metabolic Diseases
Director: Carmella Evans- Molina, MD, PhD

Indiana Center for Musculoskeletal Health